Neoadjuvant therapy for ovarian cancer

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2018Publisher:AME Publishing CompanyJournal:Chinese Clinical Oncology, volume 7, pages 54-54 (issn: 2304-3865, eissn: 2304-3873,

Copyright policy )

Authors: Evgeny N, Imyanitov;

doi: 10.21037/cco.2018.10.07

pmid: 30509076

Neoadjuvant therapy for ovarian cancer

- Summary
- Subjects
- Metrics

Abstract

Ovarian cancer (OC) is a common oncological disease, which affects approximately 1.5% of women and holds the first position in the structure of gynecological cancer mortality.

Related Organizations

Institute of Oncology NN Petrov
Russian Federation
Saint Petersburg State Pediatric Medical University
Russian Federation
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
N.N. Petrov Institute of Oncology
Russian Federation
St Petersburg University
Russian Federation

Keywords

Ovarian Neoplasms, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Prognosis, Neoadjuvant Therapy

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average